 |
| Dr Gareth Gregory |
Monash researcher and haematologist Dr Gareth Gregory has
been awarded a prestigious Sylvia and Charles Viertel Charitable Foundation
Clinical Investigator Award to further his research into aggressive lymphoma.
The $85,000 award will enable Dr Gregory and his team to use
a sophisticated genetic screen to determine mechanisms of drug resistance in
patients.
Dr Gregory said there are a number of exciting new targeted
therapies being assessed for treatment of patients with resistant aggressive
lymphomas, including numerous clinical trials at the Monash Health Translation
Precinct (MHTP).
“We see mixed responses to these treatments, whereby some
patients achieve rapid and durable remissions whereas others have lymphoma that
may also be resistant to the targeted drug,” Dr Gregory said.
“Genetic screening will assist us to more accurately predict
which patients will benefit from a new class of drug under investigation, and
those who are likely to be resistant so that an alternative treatment can be
sought.”
“This research complements other studies within the Blood
Cancer Therapeutics Laboratory headed by Associate Professor Jake Shortt, and
is an example of the growing haematology translational research activity within
the MHTP,” Dr Gregory said.
Dr Gregory is an Early Career Practitioner Fellow in the
School of Clinical Sciences at Monash Health (SCS) and Clinical Trials Lead for
aggressive lymphoma at Monash Health.
No comments:
Post a Comment